In ₹ Crore except Per Share Latest Annual | MANYAVAR FY25 | ABFRL FY26 | MEDPLUS FY26 | MSTCLTD FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 35.88× | — | 35.94× | ◆ 23.65× | 29.80× +20% | |
| P/B | — | ◆ 0.99× | 4.01× | 5.72× | 4.01× | |
| EV/EBITDA | — | ◆ 10.31× | 12.69× | 21.23× | 12.69× | |
| Market Cap | — | ₹6,215 Cr | ₹7,909 Cr | ₹5,167 Cr | ₹6,215 Cr | |
| Growth | ||||||
| Revenue CAGR 3Y | 10.03% | -13.00% | ◆ 14.78% | -19.96% | -13.00% +177% | |
| Revenue CAGR 5Y | — | 9.27% | ◆ 17.56% | -13.88% | 9.27% | |
| Net Income CAGR 3Y | 7.25% | — | ◆ 63.65% | -3.35% | 30.15% -76% | |
| Revenue YoY (latest Q) | ◆ 22.74% | 10.60% | 21.84% | 21.72% | 21.72% +5% | |
| Net Income YoY (latest Q) | 37.31% | -6.42% | -21.67% | ◆ 37.50% | -6.42% +681% | |
| Profitability | ||||||
| EBITDA Margin | 46.35% | 8.04% | 8.81% | ◆ 60.63% | 8.81% +426% | |
| Net Income Margin | 28.02% | -10.15% | 3.19% | ◆ 59.09% | 3.19% +778% | |
| Return on Common Equity | 21.75% | -12.39% | 11.12% | ◆ 24.16% | 11.12% +96% | |
| Return on Capital Employed | 20.87% | -5.23% | 10.01% | ◆ 22.87% | 10.01% +108% | |
| Return on Assets | ◆ 14.14% | -4.67% | 5.58% | 10.86% | 5.58% +153% | |
| Credit & Quality | ||||||
| Total Debt/Equity | — | 0.27× | ◆ 0.00× | 0.16× | 0.16× | |
| Interest Coverage | ◆ 8.87× | -1.32× | 2.69× | — | 0.68× +1195% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,386 Cr | ₹8,177 Cr | ₹6,892 Cr | ₹370 Cr | ₹6,892 Cr -80% | |
| Net Income | ₹388 Cr | −₹830 Cr | ₹220 Cr | ₹218 Cr | ₹218 Cr +78% | |
| Total Assets | ₹2,747 Cr | ₹17,757 Cr | ₹3,933 Cr | ₹2,011 Cr | ₹3,933 Cr -30% | |
| EPS | ₹15.99 | ₹-6.38 | ₹18.33 | ₹31.03 | ₹18.33 -13% | |
| Book Value per Share | — | ₹51.31 | ₹164.48 | ₹128.4 | ₹128.4 | |